127 related articles for article (PubMed ID: 8459056)
1. Thrombin inhibitors in unstable angina: rebound or continuation of angina after argatroban withdrawal?
Willerson JT; Casscells W
J Am Coll Cardiol; 1993 Apr; 21(5):1048-51. PubMed ID: 8459056
[No Abstract] [Full Text] [Related]
2. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
[TBL] [Abstract][Full Text] [Related]
3. Accelerated thrombin generation during anticoagulation in patients with unstable angina pectoris.
Garabedian HD; Gold HK; Newell JB; Collen D; Hagstrom JN; Bovill EG
Blood; 1994 Feb; 83(4):1155. PubMed ID: 8111056
[No Abstract] [Full Text] [Related]
4. Argatroban: a synthetic thrombin inhibitor of low relative molecular mass.
Fitzgerald D; Murphy N
Coron Artery Dis; 1996 Jun; 7(6):455-8. PubMed ID: 8889361
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of argatroban on thrombin-antithrombin III complex after percutaneous transluminal coronary angioplasty.
Sakamoto S; Hirase T; Suzuki S; Tsukamoto T; Miki T; Yamada T; Matsuo T
Thromb Haemost; 1995 Aug; 74(2):801-2. PubMed ID: 8585029
[No Abstract] [Full Text] [Related]
6. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
Direct Thrombin Inhibitor Trialists' Collaborative Group
Lancet; 2002 Jan; 359(9303):294-302. PubMed ID: 11830196
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of the synthetic thrombin inhibitor, argatroban (MD-805).
Matsuo T; Kario K; Kodama K; Okamoto S
Semin Thromb Hemost; 1992; 18(2):155-60. PubMed ID: 1631564
[No Abstract] [Full Text] [Related]
8. Clinical management of unstable angina: the place of antithrombins and platelet GP IIb/IIIa receptor blockers.
Knudtson ML
Eur Heart J; 1995 Nov; 16 Suppl L():68-74. PubMed ID: 8869022
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor.
Xiao Z; Théroux P
Circulation; 1998 Jan; 97(3):251-6. PubMed ID: 9462526
[TBL] [Abstract][Full Text] [Related]
10. Development of argatroban, a direct thrombin inhibitor, and its clinical application.
Matsuo T; Koide M; Kario K
Semin Thromb Hemost; 1997; 23(6):517-22. PubMed ID: 9469623
[TBL] [Abstract][Full Text] [Related]
11. A specific thrombin inhibitor, argatroban, alleviates herpes zoster-associated pain.
Fujii K; Kanno Y; Konishi K; Ohgou N
J Dermatol; 2001 Apr; 28(4):200-7. PubMed ID: 11449671
[TBL] [Abstract][Full Text] [Related]
12. Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.
Bijsterveld NR; Moons AH; Meijers JC; Tijssen JG; Büller HR; Levi M; Peters RJ
J Am Coll Cardiol; 2002 Mar; 39(5):811-7. PubMed ID: 11869846
[TBL] [Abstract][Full Text] [Related]
13. The role of thrombin and thrombin inhibitors in coronary angioplasty.
Ali MN; Villarreal-Levy G; Schafer AI
Chest; 1995 Nov; 108(5):1409-19. PubMed ID: 7587450
[No Abstract] [Full Text] [Related]
14. Small-molecule direct antithrombins: argatroban.
Fareed J; Jeske WP
Best Pract Res Clin Haematol; 2004 Mar; 17(1):127-38. PubMed ID: 15171962
[TBL] [Abstract][Full Text] [Related]
15. Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor.
Matsuo T; Kario K; Chikahira Y; Nakao K; Yamada T
Br J Haematol; 1992 Nov; 82(3):627-9. PubMed ID: 1486048
[No Abstract] [Full Text] [Related]
16. [Experimental and clinical results with the thrombin inhibitor Argatroban].
Breddin HK
Hamostaseologie; 2002 Aug; 22(3):55-9. PubMed ID: 12215762
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin.
Duval N; Lunven C; O'Brien DP; Grosset A; O'Connor SE; Berry CN
Br J Pharmacol; 1996 Jun; 118(3):727-33. PubMed ID: 8762100
[TBL] [Abstract][Full Text] [Related]
18. [Argatroban, a selective thrombin inhibitor, for anticoagulant therapy during and following vascular surgery].
Fuji H; Kurasako N; Takebayashi T; Tanaka T; Sakano S; Kosogabe Y; Mano M; Nagase H
Masui; 1996 Oct; 45(10):1289-92. PubMed ID: 8937032
[TBL] [Abstract][Full Text] [Related]
19. Synthetic direct thrombin inhibitors in unstable angina - more questions than answers.
Oberhoff M; Karsch KR
Eur Heart J; 1999 Aug; 20(15):1058-60. PubMed ID: 10413631
[No Abstract] [Full Text] [Related]
20. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
Lepor NE
Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
